Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)

Autor: Gilles Breysacher, F. Masskouri, C. Choine, François Morvan, Pascal Hammel, Jean-François Seitz, P. Amoyal, J. Cretin, G. Gatineau-Sailliant, Christophe Locher, Thomas Aparicio, G. Bordes, O. Boulat, David Tougeron, I. Cumin, O. Berthelet, Anne Thirot Bidault, M. Pauwels, X. Moncoucy, Faiza Khemissa, F. Petit-Laurent, X. Adhoute, P. Prost, J.P. Lagasse, Jean-Louis Legoux, J. Ezenfis, N. Le Provost, Pierre Michel, A. Gueye, P. Pouderoux, G. Le Pessec, Julien Taieb, B. Landi, H. Fattouh, A. Azzedine, Mohamed Ramdani, Matthieu Schnee, Laurent Bedenne, Jean-Louis Jouve, C. Rebischung, J. Thaury, Ph. Rougier, C. Lobry, F. Guiliani, Jean-Baptiste Bachet, F. Ricard, L. Stefani, R. Mackiewicz, Dominique Genet, E. Cuillerier, C. Bineau, A.M. Queuniet, P. Couzigou, Jean-Marc Phelip, Eveline Boucher, B. Garcia, D. Cleau, M. Schneider, Iradj Sobhani, M. Mozer, Roger Faroux, Mohamed Gasmi, J. Charneau, Côme Lepage, Thierry Lecomte, Céline Lepère, D. Auby, Eric Terrebonne, R. Benoit, Emmanuel Mitry, D. Gargot, J. Martin, M. Baconnier, V. Derias, Achim Weber, Nadia Bouarioua, L. Chone, Catherine Lombard-Bohas, Patrick Texereau, B. Denis, May Mabro, Emilie Maillard, Sandrine Lavau-Denes, F. Di Fiore, C. Girault, J. Provençal, O. Bouche, F. Bonnetain, A. Gagnaire

Publikováno v: Annals of Oncology
Annals of Oncology, Elsevier, 2016, 27 (1), pp.121-127. ⟨10.1093/annonc/mdv491⟩

International audience; BACKGROUND:Metastatic colorectal cancer (mCRC) frequently occurs in elderly patients. However, data from a geriatric tailored randomized trial about tolerance to and the efficacy of doublet chemotherapy (CT) with irinotecan in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac758ca7bddb76218ccd2c5d481807a6
https://hal.archives-ouvertes.fr/hal-01910082

Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: a GFPC study

Autor: A, Vergnenègre, I, Monnet, C, Chouaïd, J, Hureaux, J, Mazières, G, Quéré, J N, Lombard, I, Cumin, S, Abdiche, C Nocent, Ejnaini, H, Bonnabau, Ch, Decroisette

Publikováno v: Lung Cancer
Lung Cancer, 2011, 74 (2), pp.264-267. ⟨10.1016/j.lungcan.2011.03.007⟩
Lung Cancer, Elsevier, 2011, 74 (2), pp.264-267. ⟨10.1016/j.lungcan.2011.03.007⟩

International audience; CONTEXT: Erlotinib therapy for non small-cell lung cancer (NSCLC) has mainly been evaluated in randomized trials. METHOD: OBSTAR was a multicenter, retrospective, observational study involving all patients treated with erlotin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95f909e6579959589d6438961cc2a984
https://pubmed.ncbi.nlm.nih.gov/22129858

[Thymus hyperplasia following chemotherapy]

Autor: I, Cumin, F, Mechinaud, J L, Harousseau

Publikováno v: Presse medicale (Paris, France : 1983). 25(7)

Hyperplasia of the thymus, an uncommon development following chemotherapy, raises doubt concerning possible tumor recurrence. We report a case of thymic hyperplasia in a 12-year-old girl who was given chemotherapy for a cervicomediastinal lymphoma. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2314df8c5412a94806f3f7f0b79239e3
https://pubmed.ncbi.nlm.nih.gov/8685168

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Results of a phase II study using MIP regimen (Mitomycin+ifosfamide+Cisplatin) in unresectable Non Small Cell Lung Cancer

Autor: G. Dabouis, H. Lacroix, J.P. Dutin, I. Cumin, N. Donnadieu

Publikováno v: European Journal of Cancer. 29:S165

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e05c48a7fe0c8ef45049481ebeb9b45e
https://doi.org/10.1016/0959-8049(93)91540-2